Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMBRE: Chemotherapy vs Endocrine Therapy + Abemaciclib in ER+/HER2- Metastatic Breast Cancer
NCT04158362Phase 3Active, not recruiting
- Sponsor
- Unicancer
- Start
- Jun 2020
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of abemaciclib in breast cancer, sponsored by Unicancer. Started Jun 2020; status: active, not recruiting.
02
Drugs
abemaciclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04158362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04158362.